Sreeman N. Jampana, M.D.
Internal Medicine Physician · Longview, TX
Sreeman N. Jampana, M.D. is an internal medicine physician with a practice address in Longview, Texas, and NPI 1790776466, issued on Nov 2, 2005. Check the license (Texas G8712, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Sreeman N. Jampana
- Credential
- M.D.
- Primary taxonomy
- Internal Medicine Physician 207R00000X
- License number
- G8712 TX
Self-reported in NPPES; status is on the state search - Practice location
- 1603 Judson RD, Longview, TX 75601
- Phone
- (903) 758-4491
- Enumerated
- Nov 2, 2005
- Record last updated
- Jan 11, 2012 (not updated in 14 years: call before relying on the address or phone)
- Fax
- (903) 758-0993
- Medicaid ID
- 123336301 TX
- Medicare enrollment
- Enrolled (PECOS I20100114000417); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest internal medicine physician records → All 9,175 in Texas → Look up another NPI →
Verify Sreeman N. Jampana in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license G8712Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Most of these Medicare Part D claims are vaccines, 81% of the cost of the top drugs
9,139 Medicare Part D claims for 839 beneficiaries, against an average of 3,176 among the 108,855 providers of this specialty who prescribed in Part D. Brand-name drugs were 14% of claims. 207 claims were for opioids.
Most prescribed
Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.
- Amlodipine Besylate500 claims
- Atorvastatin Calcium498 claims
- Losartan Potassium356 claims
- Pantoprazole Sodium275 claims
- Lisinopril270 claims
- Levothyroxine Sodium244 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $52.57
3 payments; by number, the most common kind was food and beverage; the largest payer was Idorsia Pharmaceuticals US Inc. The 50,334 providers of this specialty with any payment received $1,303.06 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Sreeman N. Jampana among 9,175 internal medicine physician records in Texas
Sreeman N. Jampana, M.D. is one of 9,175 internal medicine physician records with a practice address in Texas. 82% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2005, is newer than 0% of them.
- NPI issued2005 · 0% of these records are older, 91% newer
- In a Medicare fileYes · 82% of these records are
- In the CMS Doctors and Clinicians fileYes · 66% of these records are
- Graduated1975 · median 2004 among the 6,088 with a school on file
- Record last updated2012 · 49% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207R00000X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
99 internal medicine physician records list a practice address in Longview
They are 99 of the 2,066 NPPES records with a practice address in Longview, and 9,175 internal medicine physician records in Texas.
All 9,175 in Texas → Every provider in Longview → Internal Medicine Physician nationwide →
The 8 internal medicine physician records with the nearest ZIP codes
- Julia Archer, M.D.Longview, TX 756011427115617
- Joseph Beraho, M.DLongview, TX 756011639181357
- Sushama Brimmer, MDLongview, TX 756011184629990
- Carl Earnest, M.D.Longview, TX 756011699832873
- Audrey Mangwiro, M.D.Longview, TX 756011346265162
- Angela Ozment, MDLongview, TX 756011598754657
- Rozina Parveen, MDLongview, TX 756011487638532
- Roger Pearce, MDLongview, TX 756011295706273
Common questions
What is Sreeman N. Jampana, M.D.'s NPI number?
Sreeman N. Jampana, M.D.'s National Provider Identifier (NPI) is 1790776466, issued on Nov 2, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Sreeman N. Jampana, M.D. located?
The NPPES record lists a practice address at 1603 Judson RD, Longview, TX, 75601. Phone: (903) 758-4491. Providers update this record themselves, so call before visiting.
How can I verify Sreeman N. Jampana, M.D.'s license?
NPPES lists Texas license number G8712, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Sreeman N. Jampana, M.D. prescribe under Medicare Part D?
In 2024, Sreeman N. Jampana, M.D. had 9,139 Medicare Part D claims for 839 beneficiaries; the average among internal medicine physician prescribers was 3,176. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.